Cited by 225Virus-based gene therapy researchRNA Interference and Gene DeliveryImmunotherapy and Immune Responses

The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.

Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy

Balakrishnan, Balaji, Jayandharan, Giridhara·2014·Current Gene Therapy

DOI 10.2174/1566523214666140302193709

Open this paper in CoChat — free account

Abstract

Adeno-associated virus (AAV) based vectors have emerged as important tools for gene therapy in humans. The recent successes seen in Phase I/II clinical trials have also highlighted the issues related to the host and vector-related immune response that preclude the universal application of this promising vector system. A fundamental insight into the biological mechanisms by which AAV infects the host cell and a thorough understanding of the immediate and long-lived cellular responses to AAV infection is likely to offer clues and help design better intervention strategies to improve the therapeutic efficiency of AAV vectors. This article reviews the biology of AAV-host cellular interactions and outlines their application in the development of novel and improved AAV vector systems.

Integrity signals

Registry

Crossref · 10.2174/1566523214666140302193709

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
Effect of gene therapy on visual function in Leber’s congenital amaurosis
Bainbridge, J. W. B., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802268 · Cited by 1,924
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“Based on in vivo studies, vectors specific to retina (AAV2, AAV4 and AAV5) [64-68], brain (AAV2, AAV5, AAV8, AAV9 and AAVrh10) [69-78], cardiac tissue (AAV1, AAV2, AAV6, AAV8 and AAV9) [79-83], liver (AAV1, AAV2, AAV5, AAV6, AAV7, AAV8, AAV9 and AAV10) [49, 84-93] and lungs (AAV1, AAV2, AAV5 and AAV9) [86-89, 92-98] h…”
Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 2×
“Based on in vivo studies, vectors specific to retina (AAV2, AAV4 and AAV5) [64-68], brain (AAV2, AAV5, AAV8, AAV9 and AAVrh10) [69-78], cardiac tissue (AAV1, AAV2, AAV6, AAV8 and AAV9) [79-83], liver (AAV1, AAV2, AAV5, AAV6, AAV7, AAV8, AAV9 and AAV10) [49, 84-93] and lungs (AAV1, AAV2, AAV5 and AAV9) [86-89, 92-98] h…”
Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070

Show all 186 references

Sorted by citations

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Naso, M. F., Tomkowicz, B., Perry, W. L., & Strohl, W. R. (2017) · BioDrugs · doi:10.1007/s40259-017-0234-5 · Cited by 1,362
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
Ronzitti, G., Gross, D.-A., & Mingozzi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00670 · Cited by 357
Overcoming innate immune barriers that impede AAV gene therapy vectors
Muhuri, M., Maeda, Y., Ma, H., Ram, S., Fitzgerald, K. A., Tai, P. W. L., & Gao, G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143780 · Cited by 212
Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
Saraiva, J., Nobre, R. J., & Pereira de Almeida, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.011 · Cited by 201
Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery
Nidetz, N. F., McGee, M. C., Tse, L. V., Li, C., Cong, L., Li, Y., & Huang, W. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107453 · Cited by 174
Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis
Yang, Y.-S., Xie, J., Wang, D., Kim, J., Tai, P. W. L., Gravallese, E. M., Gao, G., & Shim, J. (2019) · Nature Communications · doi:10.1038/s41467-019-10809-6 · Cited by 149
Adeno-associated virus in the liver: natural history and consequences in tumour development
Bella, T. L., Imbeaud, S., Péneau, C., Mami, I., Datta, S., Bayard, Q., Caruso, S., Hirsch, T. Z., Caldéraro, J., Morcrette, G., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318281 · Cited by 130
Journey to the Center of the Cell: Tracing the Path of AAV Transduction
Dhungel, B. P., Bailey, C. G., & Rasko, J. E. J. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.010 · Cited by 122
Adeno-associated Virus Vectors in Gene Therapy
Mary, B., Khan, N., Arumugam, S., Saxena, H., Kumar, M., Manimaran, P., Chattopadhyay, S., & Jayandharan, G. R. (2018) · Springer eBooks · doi:10.1007/978-981-13-0481-1_2 · Cited by 126
Self-citation
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
Yang, T., Braun, M., Lembke, W., McBlane, F., Kamerud, J., DeWall, S. L., Tarcsa, E., Fang, X., Hofer, L., Kavita, U., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.018 · Cited by 122
Post‐translational modifications in capsid proteins of recombinant adeno‐associated virus ( AAV ) 1‐rh10 serotypes
Mary, B., Maurya, S., Arumugam, S., Kumar, V. S., & Jayandharan, G. R. (2019) · FEBS Journal · doi:10.1111/febs.15013 · Cited by 105
Self-citation
Nanocarrier vaccines for SARS-CoV-2
Machhi, J., Shahjin, F., Das, S., Patel, M., Abdelmoaty, M. M., Cohen, J. D., Singh, P. A., Baldi, A., Bajwa, N., Kumar, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.002 · Cited by 100
Approved and marketed nanoparticles for disease targeting and applications in COVID-19
Abdellatif, A. A. H., & Alsowinea, A. F. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0115 · Cited by 105
Efficient gene delivery into cell lines and stem cells using baculovirus
Sung, L., Chen, C.-L., Lin, S.-Y., Li, K.-C., Yeh, C.-L., Chen, G., Lin, C., & Hu, Y. C. (2014) · Nature Protocols · doi:10.1038/nprot.2014.130 · Cited by 92
Dissecting the Role of Subtypes of Gastrointestinal Vagal Afferents
Wang, Y. B., de Lartigue, G., & Page, A. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00643 · Cited by 96
Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms
Robert, M., Chahal, P. S., Audy, A., Kamen, A., Gilbert, R., & Gaillet, B. (2017) · Biotechnology Journal · doi:10.1002/biot.201600193 · Cited by 89
Clinical development on the frontier: gene therapy for duchenne muscular dystrophy
Asher, D. R., Thapa, K., Dharia, S. D., Khan, N., Potter, R. A., Rodino‐Klapac, L. R., & Mendell, J. R. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1725469 · Cited by 91
Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants
Bouazzaoui, A., Abdellatif, A. A. H., Al-Allaf, F. A., Bogari, N. M., Al-Dehlawi, S., & Qari, S. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020140 · Cited by 92
Gene Therapy for Regenerative Medicine
Hosseinkhani, H., Domb, A. J., Sharifzadeh, G., & Nahum, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030856 · Cited by 89
The Different Faces of Rolling-Circle Replication and Its Multifunctional Initiator Proteins
Wawrzyniak, P., Płucienniczak, G., & Bartosik, D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02353 · Cited by 84
Harnessing nanoparticles for the efficient delivery of the CRISPR/Cas9 system
Rahimi, H., Salehiabar, M., Charmi, J., Barsbay, M., Ghaffarlou, M., Razlighi, M. R., Davaran, S., Khalilov, R. I., Sugiyama, M., Nosrati, H., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100895 · Cited by 83
Muscle Atrophy: Present and Future
Cao, R. Y., Li, J., Dai, Q., Li, Q. X., & Yang, J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_29 · Cited by 80
Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
Rapti, K., & Grimm, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753467 · Cited by 73
Automated Glycan Assembly of Oligo-N-Acetyllactosamine and Keratan Sulfate Probes to Study Virus-Glycan Interactions
Hahm, H. S., Broecker, F., Kawasaki, F., Mietzsch, M., Heilbronn, R., Fukuda, M., & Seeberger, P. H. (2017) · Chem · doi:10.1016/j.chempr.2016.12.004 · Cited by 70
Evolving AAV-delivered therapeutics towards ultimate cures
He, X., Urip, B. A., Zhang, Z., Ngan, C. C., & Feng, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02034-2 · Cited by 70
Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients
Gross, D., Tedesco, N., Leborgne, C., & Ronzitti, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857276 · Cited by 64
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
Fuchs, S. P., & Desrosiers, R. C. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.68 · Cited by 61
Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors
Rice-Boucher, P. J., Cui, X., & Curiel, D. T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.003 · Cited by 62
Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development
Massaro, G., Geard, A. F., Liu, W., Coombe-Tennant, O., Waddington, S. N., Baruteau, J., Gissen, P., & Rahim, A. A. (2021) · Biomolecules · doi:10.3390/biom11040611 · Cited by 64
Gene-Based Therapeutics for Inherited Retinal Diseases
Fenner, B. J., Tan, T., Barathi, V. A., Tun, S. B. B., Yeo, S. W., Tsai, A. S. H., Lee, S. Y., Cheung, C. M. G., Chan, C. M., Mehta, J. S., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.794805 · Cited by 63
AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 66
Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
Ramlogan‐Steel, C. A., Murali, A., Andrzejewski, S., Dhungel, B. P., Steel, J. C., & Layton, C. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13416 · Cited by 60
Materials promoting viral gene delivery
Kaygisiz, K., & Synatschke, C. V. (2020) · Biomaterials Science · doi:10.1039/d0bm01367f · Cited by 57
Bioinspired Underwater Propulsors
Buren, T. W. V., Floryan, D., & Smits, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781139058995.006 · Cited by 57
Safety of Adeno-associated virus-based vector-mediated gene therapy—impact of vector dose
Maurya, S., Sarangi, P., & Jayandharan, G. R. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00413-6 · Cited by 55
Self-citation
Assessment of quality attributes for adeno‐associated viral vectors
Tustian, A. D., & Bak, H. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27905 · Cited by 53
U7 snRNA: A tool for gene therapy
Gadgil, A., & Raczyńska, K. D. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3321 · Cited by 52
Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies
Burdett, T., & Nuseibeh, S. (2022) · Gene Therapy · doi:10.1038/s41434-022-00363-0 · Cited by 52
Progress and challenges of gene therapy for Pompe disease
Ronzitti, G., Collaud, F., Laforêt, P., & Mingozzi, F. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.67 · Cited by 54
Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
Yang, Y.-S., Xie, J., Chaugule, S. R., Wang, D., Kim, J., Kim, J., Tai, P. W. L., Seo, S. K., Gravallese, E. M., Gao, G., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.010 · Cited by 52
Structural dynamics, phase behavior, and applications of polyelectrolyte complex micelles
Shah, S. A., & Leon, L. (2021) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2021.101424 · Cited by 52
Low incidence of hepatocellular carcinoma in mice and cats treated with systemic adeno-associated viral vectors
Ferla, R., Alliegro, M., Dell’Anno, M., Nusco, E., Cullen, J. M., Smith, S. N., Wolfsberg, T. G., O’Donnell, P., Wang, P., Nguyen, A., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.11.015 · Cited by 51
Droplet Digital PCR Detection of the Erythropoietin Transgene from Horse Plasma and Urine for Gene-Doping Control
Tozaki, T., Ohnuma, A., Takasu, M., Kikuchi, M., Kakoi, H., HIROTA, K.-I., Kusano, K., & NAGATA, S.-I. (2019) · Genes · doi:10.3390/genes10030243 · Cited by 50
Gene Therapy Developments for Pompe Disease
Unnisa, Z., Yoon, J. K., Schindler, J. W., Mason, C., & van Til, N. P. (2022) · Biomedicines · doi:10.3390/biomedicines10020302 · Cited by 53
Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
Xu, L., Yao, S., Ding, Y. E., Xie, M., Feng, D., Sha, P., Tan, L., Bei, F., & Yao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05661-2 · Cited by 48
Single-Stranded DNA-Packaged Polyplex Micelle as Adeno-Associated-Virus-Inspired Compact Vector to Systemically Target Stroma-Rich Pancreatic Cancer
Tockary, T. A., Foo, W., Dirisala, A., Chen, Q., Uchida, S., Osawa, S., Mochida, Y., Liu, X., Kinoh, H., Cabral, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b04676 · Cited by 42
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery
Yang, Y.-S., Kim, J., Xie, J., Chaugule, S. R., Lin, C., Ma, H., Hsiao, E. C., Hong, J., Chun, H., Shore, E. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33956-9 · Cited by 46
Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates
Ballon, D., Rosenberg, J. B., Fung, E. K., Nikolopoulou, A., Kothari, P. J., De, B. P., He, B., Chen, A., Heier, L., Sondhi, D., et al. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.116 · Cited by 40
Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species
Fader, K. A., Pardo, I. D. R., Kovi, R. C., Somps, C. J., Wang, H. H., Vaidya, V. S., Ramaiah, S. K., & Sirivelu, M. P. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.03.017 · Cited by 41
Gene Therapy for Mucopolysaccharidosis Type II—A Review of the Current Possibilities
Zapolnik, P., & Pyrkosz, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115490 · Cited by 39
Baculovirus-Mediated miRNA Regulation to Suppress Hepatocellular Carcinoma Tumorigenicity and Metastasis
Chen, C.-L., Wu, J., Chen, G., Yuan, P.-H., Tseng, Y.-W., Li, K.-C., Hwang, S., & Hu, Y.-C. (2014) · Molecular Therapy · doi:10.1038/mt.2014.126 · Cited by 37
Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method
Patton, K. S., Harrison, M. T., Long, B. R., Lau, K., Holcomb, J., Owen, R. E., Kasprzyk, T., Janetzki, S., Zoog, S. J., & Vettermann, C. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.012 · Cited by 38
Gene therapy for genetic diseases: challenges and future directions
Beibei, Q. I. E., Tuo, J., Chen, F., Ding, H., & Lyu, L. (2025) · MedComm · doi:10.1002/mco2.70091 · Cited by 38
Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivo
Li, H., Sun, B., Huang, Y., Zhang, J., Xu, X., Shen, Y., Chen, Z., Yang, J., Shen, L., Hu, Y., et al. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00456-x · Cited by 35
Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
Dreismann, A. K., Hallam, T. M., Tam, L. C. S., Nguyen, C. V., Hughes, J. P., Ellis, S., & Harris, C. L. (2022) · Immunological Reviews · doi:10.1111/imr.13149 · Cited by 36
Viral Vector-Mediated Antisense Therapy for Genetic Diseases
Imbert, M., Dias-Florencio, G., & Goyenvalle, A. (2017) · Genes · doi:10.3390/genes8020051 · Cited by 35
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Zhan, W., Muhuri, M., Tai, P. W. L., & Gao, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673699 · Cited by 35
A Roadmap for the Success of Oncolytic Parvovirus-Based Anticancer Therapies
Hartley, A., Kavishwar, G., Salvato, I., & Marchini, A. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-012220-023606 · Cited by 31
Manipulation of mitochondrial genes and mtDNA heteroplasmy
Bacman, S. R., Gammage, P. A., Minczuk, M. A., & Moraes, C. T. (2020) · Methods in cell biology · doi:10.1016/bs.mcb.2019.12.004 · Cited by 30
Programmable Assembly of Adeno-Associated Virus–Antibody Composites for Receptor-Mediated Gene Delivery
Zdechlik, A. C., He, Y., Aird, E. J., Gordon, W. R., & Schmidt, D. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00790 · Cited by 30
Relationship between neutralizing antibodies against adeno-associated virus in the vitreous and serum: effects on retinal gene therapy
Lee, S., Kang, I. K., Kim, J. H., Jung, B. K., Park, K., Chang, H., Lee, J. Y., & Lee, H. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.2.14 · Cited by 27
Rapid, scalable, and low-cost purification of recombinant adeno-associated virus produced by baculovirus expression vector system
Buclez, P.-O., Leite, G. D. F., Relizani, K., Beley, C., García, L., & Benchaouir, R. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.35 · Cited by 26
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters
Yan, K., Feng, J., Liu, X., Wang, H., Li, Q., Li, J., Xu, T., Sajid, M., Ullah, H., Zhou, L., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.665184 · Cited by 28
Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vectors
Hutt, J. A., Assaf, B. T., Bolon, B. N., Cavagnaro, J. A., Galbreath, E. J., Grubor, B., Kattenhorn, L. M., Romeike, A., & Whiteley, L. O. (2021) · Toxicologic Pathology · doi:10.1177/01926233211041962 · Cited by 27
PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations
Shmidt, A. A., & Egorova, T. V. (2021) · Pharmaceuticals · doi:10.3390/ph15010023 · Cited by 27
Genetic Therapy Approaches for Ornithine Transcarbamylase Deficiency
Yılmaz, B. Ş., & Gissen, P. (2023) · Biomedicines · doi:10.3390/biomedicines11082227 · Cited by 26
Systemic administration of AAV-Slc25a46 mitigates mitochondrial neuropathy in Slc25a46−/− mice
Yang, L., Slone, J. D., Li, Z., Lou, X., Hu, Y., Queme, L. F., Jankowski, M. P., & Huang, T. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz277 · Cited by 27
Accurate Quantification of AAV Vector Genomes by Quantitative PCR
de la Cámara, C. M.-F., McClements, M. E., & MacLaren, R. E. (2021) · Genes · doi:10.3390/genes12040601 · Cited by 26
In vivo CAR cell therapy: from bench to bedside
Jia, X., Chen, Z., Su, L., Ren, A., & Mei, H. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01759-2 · Cited by 30
Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma
Dhungel, B. P., Jayachandran, A., Layton, C. J., & Steel, J. C. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1247926 · Cited by 24
Current AAV-mediated gene therapy in sensorineural hearing loss
Qi, J., Fu, X., Zhang, L., Tan, F., Li, N., Sun, Q., Hu, X., He, Z., Xia, M., & Chai, R. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.08.015 · Cited by 24
Precision Fluorescent Labeling of an Adeno‐Associated Virus Vector to Monitor the Viral Infection Pathway
Zhang, C., Zhou, X., Yao, T., Tian, Z., & Zhou, D. (2018) · Biotechnology Journal · doi:10.1002/biot.201700374 · Cited by 25
Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8+ T Cells in Human Donors Allows the Detection of a TEMRA Subpopulation
Vandamme, C., Xicluna, R., Hesnard, L., Devaux, M., Jaulin, N., Guilbaud, M., Le Duff, J., Couzinié, C., Moullier, P., Saulquin, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03110 · Cited by 23
Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
Repudi, S., Kustanovich, I. M., Abu‐Swai, S., Stern, S., & Aqeilan, R. I. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202114599 · Cited by 23
Prospects for gene replacement therapies in amyotrophic lateral sclerosis
Giovannelli, I., Higginbottom, A., Kirby, J., Azzouz, M., & Shaw, P. J. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00751-5 · Cited by 23
Characterization of Virus Particles and Submicron-Sized Particulate Impurities in Recombinant Adeno-Associated Virus Drug Product
Hiemenz, C., Pacios-Michelena, A., Helbig, C., Vezočnik, V., Strebl, M., Nikels, F., Hawe, A., Garidel, P., & Menzen, T. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.05.009 · Cited by 22
Cellular unfolded protein response against viruses used in gene therapy
Sen, D., Balakrishnan, B., & Jayandharan, G. R. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00250 · Cited by 24
Self-citation
Superior human hepatocyte transduction with adeno-associated virus vector serotype 7
Shao, W., Pei, X., Cui, C., Askew, C., Dobbins, A., Chen, X., Abajas, Y. L., Gerber, D. A., Samulski, R. J., Nichols, T. C., et al. (2019) · Gene Therapy · doi:10.1038/s41434-019-0104-5 · Cited by 22
A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
Silva-Pilipich, N., Smerdou, C., & Vanrell, L. (2021) · Microorganisms · doi:10.3390/microorganisms9091956 · Cited by 22
A robust and efficient alluvial filtration method for the clarification of adeno-associated viruses from crude cell lysates
Meierrieks, F., Pickl, A., & Wolff, M. W. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.03.010 · Cited by 23
Endocytosis in gene therapy with non-viral vectors
de Garibay, A. P. R. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0450-5 · Cited by 21
Inducible HEK293 AAV packaging cell lines expressing Rep proteins
Jalšić, L., Lytvyn, V., Elahi, S. M., Hrapovic, S., Nassoury, N., Chahal, P. S., Gaillet, B., & Gilbert, R. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.07.002 · Cited by 27
Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 19
Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids
Wang, J., Zhang, L., Wu, G., Wu, J., Zhou, X., Chen, X., Liu, Q., Jiao, Y., Liu, Q., Liang, P., et al. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.04.013 · Cited by 20
Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
Horgan, C., Jones, S. A., Bigger, B., & Wynn, R. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094854 · Cited by 18
Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases
Shamshad, A., Kang, C., Jenny, L. A., Persad‐Paisley, E. M., & Tsang, S. H. (2023) · Vision Research · doi:10.1016/j.visres.2023.108258 · Cited by 16
Distinct chemical degradation pathways of AAV1 and AAV8 under thermal stress conditions revealed by analytical anion exchange chromatography and LC-MS-based peptide mapping
Xing, T., Li, S., Tang, S., Huang, Y., Liu, G., Yan, Y., Liu, D., Wang, S., Zhi, L., Shameem, M., et al. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116452 · Cited by 16
Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality
Ohba, K., Sehara, Y., Enoki, T., Mineno, J., Ozawa, K., & Mizukami, H. (2023) · iScience · doi:10.1016/j.isci.2023.106487 · Cited by 16
Biophysical characterization of adeno-associated virus capsid through the viral transduction life cycle
Xiang, Y. S., & Hao, G. G. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00518-5 · Cited by 18
Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinic
Singh, M., Brööks, A. G., Toofan, P., & McLuckie, K. (2023) · Gene Therapy · doi:10.1038/s41434-023-00417-x · Cited by 16
Context-Specific Function of the Engineered Peptide Domain of PHP.B
Martino, R. A., Fluck, E. C., Murphy, J., Wang, Q., Hoff, H. B., Pumroy, R. A., Lee, C. Y., Sims, J. J., Roy, S., Moiseenkova‐Bell, V. Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01164-21 · Cited by 17
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy
Stolte, B., Schreiber-Katz, O., Günther, R., Wurster, C. D., Petri, S., Osmanovic, A., Freigang, M., Uzelac, Z., Leo, M., von Velsen, O., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.054 · Cited by 15
Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications
Egorova, T. V., Starikova, A. V., & Polikarpova, A. V. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111492 · Cited by 18
A Novel and Simplified Anion Exchange Flow‐Through Polishing Approach for the Separation of Full From Empty Adeno‐Associated Virus Capsids
Meierrieks, F., Weltken, A., Pflanz, K. B., Pickl, A., Graf, B., & Wolff, M. W. (2024) · Biotechnology Journal · doi:10.1002/biot.202400430 · Cited by 16
Progress in AAV-Mediated In Vivo Gene Therapy and Its Applications in Central Nervous System Diseases
Wang, S., & Xiao, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052213 · Cited by 18
Optimized Subretinal Injection Technique for Gene Therapy Approaches
Mühlfriedel, R., Michalakis, S., Garrido, M. G., Sothilingam, V., Schön, C., Biel, M., & Seeliger, M. W. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8669-9_26 · Cited by 14
Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis
Bu, F., Jia, P., Zhu, Y. Y., Yang, Y., Meng, H., Bi, Y., Huang, C., & Li, J. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.06.009 · Cited by 14

Authors: Balakrishnan, B., & Jayandharan, G.
Affiliations: Bentham Science Publishers (United Arab Emirates) (AE)
Christian Medical College, Vellore (IN)
ORCID: Balakrishnan, Balaji
Jayandharan, Giridhara
Venue: Current Gene Therapy
Publisher: Bentham Science Publishers Ltd.
Published: 2014-05-31
Volume: 14
Issue: 2
Pages: 86-100
ISSN: 1566-5232 (ISSN-L)
DOI: 10.2174/1566523214666140302193709
OpenAlex: W2142695353
Cited by: 225
References: 186
Citations by year: 2026: 6 · 2025: 29 · 2024: 22 · 2023: 24 · 2022: 24 · 2021: 28 · 2020: 37 · 2019: 18 · 2018: 13 · 2017: 13 · 2016: 7 · 2015: 1 · 2014: 3
FWCI: 5.24
Type: journal article
Language: en
Open access: closed
Locations: Current Gene Therapy (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: adeno-associated virus, adeno-associated virus vectors, gene therapy vectors, host immune response, vector immunogenicity, vector design
MeSH terms: Dependovirus, Genetic Vectors, Humans, Genetic Therapy, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic, Gene Transfer Techniques, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks